Find Mavacamten manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Camzyos, 1642288-47-8, Mavacamten [inn], Mavacamten [usan], Mavacamten [who-dd], Myk-461
Molecular Formula
C15H19N3O2
Molecular Weight
273.33  g/mol
InChI Key
RLCLASQCAPXVLM-NSHDSACASA-N
FDA UNII
QX45B99R3J

Mavacamten
Mavacamten is under investigation in clinical trial NCT03442764 (A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)).
1 2D Structure

Mavacamten

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
6-[[(1S)-1-phenylethyl]amino]-3-propan-2-yl-1H-pyrimidine-2,4-dione
2.1.2 InChI
InChI=1S/C15H19N3O2/c1-10(2)18-14(19)9-13(17-15(18)20)16-11(3)12-7-5-4-6-8-12/h4-11,16H,1-3H3,(H,17,20)/t11-/m0/s1
2.1.3 InChI Key
RLCLASQCAPXVLM-NSHDSACASA-N
2.1.4 Canonical SMILES
CC(C)N1C(=O)C=C(NC1=O)NC(C)C2=CC=CC=C2
2.1.5 Isomeric SMILES
C[C@@H](C1=CC=CC=C1)NC2=CC(=O)N(C(=O)N2)C(C)C
2.2 Other Identifiers
2.2.1 UNII
QX45B99R3J
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Myk-461

2.3.2 Depositor-Supplied Synonyms

1. Camzyos

2. 1642288-47-8

3. Mavacamten [inn]

4. Mavacamten [usan]

5. Mavacamten [who-dd]

6. Myk-461

7. 6-[[(1s)-1-phenylethyl]amino]-3-propan-2-yl-1h-pyrimidine-2,4-dione

8. Qx45b99r3j

9. Sar-439152

10. (s)-3-isopropyl-6-((1-phenylethyl)amino)pyrimidine-2,4(1h,3h)-dione

11. Sar439152

12. 2,4(1h,3h)-pyrimidinedione, 3-(1-methylethyl)-6-(((1s)-1-phenylethyl)amino)-

13. 2,4(1h,3h)-pyrimidinedione, 3-(1-methylethyl)-6-[[(1s)-1-phenylethyl]amino]-

14. Mavacamten (myk-461)

15. Unii-qx45b99r3j

16. Myk461

17. Chembl4297517

18. Schembl16320785

19. Gtpl11265

20. Ex-a2072

21. Bdbm50575174

22. S8861

23. Who 10492

24. Db14921

25. Myk-461; Mavacamten; Sar439152

26. Sar-439152; Myk-461

27. Hy-109037

28. Cs-0031211

29. E83742

30. (s)-3-isopropyl-6-((1-phenylethyl)amino) Pyrimidine-2,4(1h,3h)-dione

31. (s)-3-isopropyl-6-((1-phenylethyl)amino)pyrimidine-2, 4(1h,3h)-dione

32. (s)-3-isopropyl-6-(1-phenylethylamino)pyrimidine-2,4(1h,3h)-dione

33. 3-(1-methylethyl)-6-[[(1s)-1-phenylethyl]amino]-2,4(1h,3h)-pyrimidinedione

34. 6-(((1s)-1-phenylethyl)amino)-3-(propan-2-yl)-1,2,3,4 Tetrahydropyrimidine-2,4-dione

35. 6-{[(1s)-1-phenylethyl]amino}-3-(propan-2-yl)pyrimidine-2,4(1h,3h)-dione

2.4 Create Date
2016-02-23
3 Chemical and Physical Properties
Molecular Weight 273.33 g/mol
Molecular Formula C15H19N3O2
XLogP32.1
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count3
Rotatable Bond Count4
Exact Mass273.147726857 g/mol
Monoisotopic Mass273.147726857 g/mol
Topological Polar Surface Area61.4 Ų
Heavy Atom Count20
Formal Charge0
Complexity411
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Treatment of hypertrophic cardiomyopathy


API SUPPLIERS

read-more
read-more

01

Metrochem API Private Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Metrochem

02

Moehs Iberica

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMoehs Group, a reference company in the production of pharmaceutical active ingredients.

Flag Spain
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Moehs Iberica

03

Inke S.A

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothInke S.A: APIs manufacturing plant.

Flag Spain
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Inke Company Banner

04

Nuray Chemicals Private Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Nuray Chemicals

05

Dr. Reddy's Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Dr Reddy Company Banner

06

Shandong Chenghui Shuangda Pharmac...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothChina's leading API and intermediate manufacturer, offering CMO/CDMO services and exports to 70+ countries, enhancing global health.

Flag China
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Shandong Chenghui Shuangda Pharmaceutical

07

HRV Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Pharma - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
HRV Global Life Sciences

08

Tagoor Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Tagoor Laboratories

09

TAPI Technology & API Services

Israel

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Flag Israel
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
TAPI Company Banner

10

Maithri Drugs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMaithri Drugs: Dedicated to your API needs.

Flag India
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF BR arrow-down AUDIT
Company Banner
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMoehs Group, a reference company in the production of pharmaceutical active ingredients.

Flag Spain
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 38462

Submission : 2023-06-22

Status : Active

Type : II

Moehs Iberica

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMaithri Drugs: Dedicated to your API needs.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 39772

Submission : 2024-03-29

Status : Active

Type : II

Company Banner

03

OPRD
Not Confirmed

03

OPRD
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2025-05-06

Pay. Date : 2025-04-04

DMF Number : 41326

Submission : 2025-03-25

Status : Active

Type : II

blank

04

OPRD
Not Confirmed

05

Micro Labs Ltd

India

USDMF

arrow
OPRD
Not Confirmed

05

OPRD
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 41418

Submission : 2025-05-14

Status : Active

Type : II

blank

06

OPRD
Not Confirmed

07

Dr Reddys Laboratories Ltd

Country

USDMF

arrow
OPRD
Not Confirmed

07

Dr Reddys Laboratories Ltd

Country
arrow
OPRD
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 41081

Submission : 2024-12-31

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

PackExpo
Not Confirmed
arrow
arrow
PackExpo
Not Confirmed

MAVACAMTEN

NDC Package Code : 69988-0060

Start Marketing Date : 2022-04-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/1)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

02

PackExpo
Not Confirmed
arrow
arrow
PackExpo
Not Confirmed

MAVACAMTEN

NDC Package Code : 81666-008

Start Marketing Date : 2025-03-20

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

03

PackExpo
Not Confirmed
arrow
arrow
PackExpo
Not Confirmed

MAVACAMTEN

NDC Package Code : 70600-050

Start Marketing Date : 2024-03-20

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

04

PackExpo
Not Confirmed
arrow
arrow
PackExpo
Not Confirmed

MAVACAMTEN

NDC Package Code : 50193-4423

Start Marketing Date : 2024-12-09

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

05

PPL Pharma Solutions Riverview LLC

Country
PackExpo
Not Confirmed
arrow

PPL Pharma Solutions Riverview LLC

Country
arrow
PackExpo
Not Confirmed

MAVACAMTEN

NDC Package Code : 48957-0091

Start Marketing Date : 2022-04-28

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Flag India
Digital Content Digital Content

Mavacamten

About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...

Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product groups and has been approved by ISO 9001-2015, USFDA, WHO GMP, Cofepris & Japanese authorities. Metrochem’s in-depth industry knowledge, & hi-tech & advanced infrastructure, helps it provide quality products to its customers. Note: None of the products will be supplied to the countries where this could conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer
Metrochem

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMoehs Group, a reference company in the production of pharmaceutical active ingredients.

Flag Spain
Digital Content Digital Content

Mavacamten

About the Company : Since its founding in 1962, MOEHS has produced Active Pharmaceutical Ingredients (APIs) for the international pharmaceutical industry. Thanks to a business history of more than 50 ...

Since its founding in 1962, MOEHS has produced Active Pharmaceutical Ingredients (APIs) for the international pharmaceutical industry. Thanks to a business history of more than 50 years, MOEHS has considerable technical experience in the production of these substances. At Moehs Group we have a large tradition and experience in the area of manufacturing of active pharmaceutical and veterinary ingredients, agrochemicals, nutraceutical, cosmetic, as well as fine chemistry in general, with high levels of quality and safety standards-GMP´s, ICH, approved by the FDA and TGA.
Moehs Iberica

03

Inke S.A

Spain
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothInke S.A: APIs manufacturing plant.

Flag Spain
Digital Content Digital Content

Mavacamten

About the Company : Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse the...

Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on behalf of US-FDA was in 2023). For the last two decades, the company has made strong strides to become a prestige provider of respiratory APIs for inhalation.
Inke Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Flag India
Digital Content Digital Content

Mavacamten

About the Company : Established in 2012, Nuray Chemicals Pvt Ltd is an API manufacturer for highly regulated markets. Its manufacturing facility with state-of-the-art R&D is located near Chennai in th...

Established in 2012, Nuray Chemicals Pvt Ltd is an API manufacturer for highly regulated markets. Its manufacturing facility with state-of-the-art R&D is located near Chennai in the Indian state of Tamil Nadu. Nuray’s expertise and experience lie in developing the chemistry requirements of the pharmaceutical industry, including the synthesis of NCEs, impurities, metabolites, method development, advanced intermediates and APIs for commercial launch. With its focus on maintaining the highest levels of quality, reliability and transparency, Nuray has emerged as a trusted partner in the global generic market.
Nuray Chemicals

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

Mavacamten

About the Company : Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfoli...

Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfolio that provides high-quality, low-cost APIs to leading pharma companies in 80+ countries. It has 8 USFDA-inspected facilities – 6 in India & 1 each in Mexico & the UK & are inspected by international regulatory authorities on a regular basis. Its facilities are supplemented by formulation facilities that provide a wide range of dosage forms. Product(s) under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act and not for commercial sale
Dr Reddy Company Banner

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothChina's leading API and intermediate manufacturer, offering CMO/CDMO services and exports to 70+ countries, enhancing global health.

Flag China
Digital Content Digital Content

Mavacamten

About the Company : Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. specializes in R&D and production of APIs and advanced intermediates, CDMO/CRO/OEM, and Technology Transfer of Finished Formulat...

Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. specializes in R&D and production of APIs and advanced intermediates, CDMO/CRO/OEM, and Technology Transfer of Finished Formulations. With 23 years of production experience, the company operates 6 GMP-compliant workshops, achieving a monthly capacity of 100 tons to meet cGMP requirements. Currently, the factory has registered 21 APIs in NMPA, filed 4 US-DMFs, and applied for 9 CEPs, while successfully passing audits by MFDS, US FDA, and global customers.
Shandong Chenghui Shuangda Pharmaceutical

07

HRV Pharma

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Pharma - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content

Mavacamten

About the Company : HRV Pharma is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...

HRV Pharma is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It offers services such as sourcing, manufacturing & supply, helping partners enter new markets worldwide. Its strong partnerships with major players in the pharma and food additive industries help HRV Pharma effectively promote projects and products. HRV Pharma represents over 30 large Indian drugmakers, primarily targeting Europe, the US & the Middle East markets. Headquartered in India, HRV Pharma has offices in the US, Switzerland, Dubai, Lithuania & Turkey.
HRV Global Life Sciences

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.

Flag India
Digital Content Digital Content

Mavacamten

About the Company : Tagoor Laboratories, established in 2018, is a part of the Tagoor Group. It specializes in providing APIs, advanced intermediates and key starting materials for critical and high-g...

Tagoor Laboratories, established in 2018, is a part of the Tagoor Group. It specializes in providing APIs, advanced intermediates and key starting materials for critical and high-growth therapeutic areas, with an emphasis on affordability, quality and timely delivery. It also provides end-to-end CDMO services. Headquartered in Hyderabad, Tagoor Labs is a fast-growing Indian pharma company that serves both branded and generic companies worldwide. The company’s organizational function includes R&D, supply chain, manufacturing, quality testing, quality assurance, regulatory affairs, marketing & sales, and packaging & warehousing departments.
Tagoor Laboratories

09

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Flag Israel
Digital Content Digital Content

Mavacamten

About the Company : Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, drivi...

Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, driving progress in the pharmaceutical industry. Leveraging our extensive experience and world-class expertise, we deliver one of the most comprehensive API portfolios in the industry with over 350 Products portfolio. Additionally, we provide tailored CDMO services, harnessing our proficiency in diverse technologies to meet our partners' unique needs, ensuring flexibility and excellence in every project.
TAPI Company Banner

10

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMaithri Drugs: Dedicated to your API needs.

Flag India
Digital Content Digital Content

Mavacamten

About the Company : Maithri Drugs Pvt. Ltd. is a trusted global partner in Active Pharmaceutical Ingredients (APIs), supplying to pharmaceutical leaders in 60+ countries. With APIs spanning antivirals...

Maithri Drugs Pvt. Ltd. is a trusted global partner in Active Pharmaceutical Ingredients (APIs), supplying to pharmaceutical leaders in 60+ countries. With APIs spanning antivirals, antibiotics, ARVs, CNS, and cardiovascular segments, we deliver innovation with reliability. Our facilities are approved by US FDA, EDQM, Health Canada, and WHO-GMP, backed by numerous global DMFs and recognition as an Ecovadis-rated company. Supported by strong R&D, global patents, and customer-centric practices, Maithri ensures world-class APIs with regulatory excellence and exceptional service.
Company Banner
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

BRISTOL

United Kingdom
BioJapan
Not Confirmed
arrow

BRISTOL

United Kingdom
arrow
BioJapan
Not Confirmed

MAVACAMTEN

Brand Name : CAMZYOS

Dosage Form : CAPSULE;ORAL

Dosage Strength : 2.5MG

Approval Date : 2022-04-28

Application Number : 214998

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

02

BRISTOL

United Kingdom
BioJapan
Not Confirmed
arrow

BRISTOL

United Kingdom
arrow
BioJapan
Not Confirmed

MAVACAMTEN

Brand Name : CAMZYOS

Dosage Form : CAPSULE;ORAL

Dosage Strength : 5MG

Approval Date : 2022-04-28

Application Number : 214998

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

03

BRISTOL

United Kingdom
BioJapan
Not Confirmed
arrow

BRISTOL

United Kingdom
arrow
BioJapan
Not Confirmed

MAVACAMTEN

Brand Name : CAMZYOS

Dosage Form : CAPSULE;ORAL

Dosage Strength : 10MG

Approval Date : 2022-04-28

Application Number : 214998

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

04

BRISTOL

United Kingdom
BioJapan
Not Confirmed
arrow

BRISTOL

United Kingdom
arrow
BioJapan
Not Confirmed

MAVACAMTEN

Brand Name : CAMZYOS

Dosage Form : CAPSULE;ORAL

Dosage Strength : 15MG

Approval Date : 2022-04-28

Application Number : 214998

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

Mavakamten

Brand Name : Camzyos

Dosage Form : Capsule

Dosage Strength : 10mg

Packaging :

Approval Date : 26/06/2023

Application Number : 20210628000045

Regulatory Info : Approved

Registration Country : Sweden

blank

02

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

Mavakamten

Brand Name : Camzyos

Dosage Form : Capsule

Dosage Strength : 15mg

Packaging :

Approval Date : 26/06/2023

Application Number : 20210628000052

Regulatory Info : Approved

Registration Country : Sweden

blank

03

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

Mavakamten

Brand Name : Camzyos

Dosage Form : Capsule

Dosage Strength : 2.5mg

Packaging :

Approval Date : 26/06/2023

Application Number : 20210628000021

Regulatory Info : Approved

Registration Country : Sweden

blank

04

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

Mavakamten

Brand Name : Camzyos

Dosage Form : Capsule

Dosage Strength : 5mg

Packaging :

Approval Date : 26/06/2023

Application Number : 20210628000038

Regulatory Info : Approved

Registration Country : Sweden

blank

05

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

Mavacamten

Brand Name : Camzyos

Dosage Form : Hard Capsule

Dosage Strength : 15MG

Packaging :

Approval Date : 2023-07-03

Application Number : 1231716008

Regulatory Info : Authorized

Registration Country : Spain

blank

06

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

Mavacamten

Brand Name : Camzyos

Dosage Form : Hard Capsule

Dosage Strength : 5MG

Packaging :

Approval Date : 2023-07-03

Application Number : 1231716004

Regulatory Info : Authorized

Registration Country : Spain

blank

07

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

Mavacamten

Brand Name : Camzyos

Dosage Form : Hard Capsule

Dosage Strength : 10MG

Packaging :

Approval Date : 2023-07-03

Application Number : 1231716006

Regulatory Info : Authorized

Registration Country : Spain

blank

08

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

Mavacamten

Brand Name : Camzyos

Dosage Form : Hard Capsule

Dosage Strength : 2.5MG

Packaging :

Approval Date : 2023-07-03

Application Number : 1231716002

Regulatory Info : Authorized

Registration Country : Spain

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Canada

read-more
read-more

01

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

MAVACAMTEN

Brand Name : CAMZYOS

Dosage Form : CAPSULE

Dosage Strength : 2.5MG

Packaging :

Approval Date :

Application Number : 2532549

Regulatory Info : Prescription

Registration Country : Canada

blank

02

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

MAVACAMTEN

Brand Name : CAMZYOS

Dosage Form : CAPSULE

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number : 2532557

Regulatory Info : Prescription

Registration Country : Canada

blank

03

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

MAVACAMTEN

Brand Name : CAMZYOS

Dosage Form : CAPSULE

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number : 2532565

Regulatory Info : Prescription

Registration Country : Canada

blank

04

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

MAVACAMTEN

Brand Name : CAMZYOS

Dosage Form : CAPSULE

Dosage Strength : 15MG

Packaging :

Approval Date :

Application Number : 2532573

Regulatory Info : Prescription

Registration Country : Canada

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Australia

read-more
read-more

01

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

mavacamten

Brand Name : Camzyos

Dosage Form :

Dosage Strength :

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

02

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

mavacamten

Brand Name : Camzyos

Dosage Form :

Dosage Strength :

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

03

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

mavacamten

Brand Name : Camzyos

Dosage Form :

Dosage Strength :

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

04

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

mavacamten

Brand Name : Camzyos

Dosage Form :

Dosage Strength :

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

05

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

mavacamten

Brand Name : Camzyos

Dosage Form :

Dosage Strength :

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

06

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

mavacamten

Brand Name : Camzyos

Dosage Form :

Dosage Strength :

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

07

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

mavacamten

Brand Name : Camzyos

Dosage Form :

Dosage Strength :

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

08

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

mavacamten

Brand Name : Camzyos

Dosage Form :

Dosage Strength :

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Annual Reports

read-more
read-more

01

Brand Name : Camzyos

Mavacamten

arrow
BioJapan
Not Confirmed

Brand Name : Camzyos

U.S.A
arrow
BioJapan
Not Confirmed

Mavacamten

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2022 Revenue in Millions : 24

2021 Revenue in Millions : 0

Growth (%) : New Launch in 2022

blank

02

Brand Name : Camzyos

Mavacamten

arrow
BioJapan
Not Confirmed

Brand Name : Camzyos

U.S.A
arrow
BioJapan
Not Confirmed

Mavacamten

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2023 Revenue in Millions : 231

2022 Revenue in Millions : 24

Growth (%) : 863

blank

03

Brand Name : Camzyos

Mavacamten

arrow
BioJapan
Not Confirmed

Brand Name : Camzyos

U.S.A
arrow
BioJapan
Not Confirmed

Mavacamten

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2024 Revenue in Millions : 602

2023 Revenue in Millions : 231

Growth (%) : 161

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

read-more
read-more

01

arrow
The Battery Show
Not Confirmed

BRISTOL

United Kingdom
arrow
The Battery Show
Not Confirmed

MAVACAMTEN

US Patent Number : RE50050

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 214998

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-06-19

blank

02

arrow
The Battery Show
Not Confirmed

BRISTOL

United Kingdom
arrow
The Battery Show
Not Confirmed

MAVACAMTEN

US Patent Number : 9585883

Drug Substance Claim :

Drug Product Claim :

Application Number : 214998

Patent Use Code : U-3373

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-06-19

blank

03

arrow
The Battery Show
Not Confirmed

BRISTOL

United Kingdom
arrow
The Battery Show
Not Confirmed

MAVACAMTEN

US Patent Number : 9585883

Drug Substance Claim :

Drug Product Claim :

Application Number : 214998

Patent Use Code : U-3373

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-06-19

blank

04

arrow
The Battery Show
Not Confirmed

BRISTOL

United Kingdom
arrow
The Battery Show
Not Confirmed

MAVACAMTEN

US Patent Number : 9585883

Drug Substance Claim :

Drug Product Claim :

Application Number : 214998

Patent Use Code : U-3373

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-06-19

blank

05

arrow
The Battery Show
Not Confirmed

BRISTOL

United Kingdom
arrow
The Battery Show
Not Confirmed

MAVACAMTEN

US Patent Number : 9585883

Drug Substance Claim :

Drug Product Claim :

Application Number : 214998

Patent Use Code : U-3373

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-06-19

blank

06

arrow
The Battery Show
Not Confirmed

BRISTOL

United Kingdom
arrow
The Battery Show
Not Confirmed

MAVACAMTEN

US Patent Number : RE50050

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 214998

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-06-19

blank

07

arrow
The Battery Show
Not Confirmed

BRISTOL

United Kingdom
arrow
The Battery Show
Not Confirmed

MAVACAMTEN

US Patent Number : RE50050

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 214998

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-06-19

blank

08

arrow
The Battery Show
Not Confirmed

BRISTOL

United Kingdom
arrow
The Battery Show
Not Confirmed

MAVACAMTEN

US Patent Number : RE50050

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 214998

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-06-19

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Looking for 1642288-47-8 / Mavacamten API manufacturers, exporters & distributors?

Mavacamten manufacturers, exporters & distributors 1

61

PharmaCompass offers a list of Mavacamten API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mavacamten manufacturer or Mavacamten supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mavacamten manufacturer or Mavacamten supplier.

PharmaCompass also assists you with knowing the Mavacamten API Price utilized in the formulation of products. Mavacamten API Price is not always fixed or binding as the Mavacamten Price is obtained through a variety of data sources. The Mavacamten Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Mavacamten

Synonyms

Camzyos, 1642288-47-8, Mavacamten [inn], Mavacamten [usan], Mavacamten [who-dd], Myk-461

Cas Number

1642288-47-8

Unique Ingredient Identifier (UNII)

QX45B99R3J

About Mavacamten

Mavacamten is under investigation in clinical trial NCT03442764 (A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)).

Mavacamten Manufacturers

A Mavacamten manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mavacamten, including repackagers and relabelers. The FDA regulates Mavacamten manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mavacamten API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Mavacamten manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Mavacamten Suppliers

A Mavacamten supplier is an individual or a company that provides Mavacamten active pharmaceutical ingredient (API) or Mavacamten finished formulations upon request. The Mavacamten suppliers may include Mavacamten API manufacturers, exporters, distributors and traders.

click here to find a list of Mavacamten suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Mavacamten USDMF

A Mavacamten DMF (Drug Master File) is a document detailing the whole manufacturing process of Mavacamten active pharmaceutical ingredient (API) in detail. Different forms of Mavacamten DMFs exist exist since differing nations have different regulations, such as Mavacamten USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Mavacamten DMF submitted to regulatory agencies in the US is known as a USDMF. Mavacamten USDMF includes data on Mavacamten's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Mavacamten USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Mavacamten suppliers with USDMF on PharmaCompass.

Mavacamten NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Mavacamten as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Mavacamten API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Mavacamten as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Mavacamten and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Mavacamten NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Mavacamten suppliers with NDC on PharmaCompass.

Mavacamten GMP

Mavacamten Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Mavacamten GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mavacamten GMP manufacturer or Mavacamten GMP API supplier for your needs.

Mavacamten CoA

A Mavacamten CoA (Certificate of Analysis) is a formal document that attests to Mavacamten's compliance with Mavacamten specifications and serves as a tool for batch-level quality control.

Mavacamten CoA mostly includes findings from lab analyses of a specific batch. For each Mavacamten CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Mavacamten may be tested according to a variety of international standards, such as European Pharmacopoeia (Mavacamten EP), Mavacamten JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mavacamten USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty